With hopes for an end to the war rising, the KOSPI index is moving around the 6,140 level on the 15th. Individuals, who led early gains, turned to net sellers, while foreigners and institutions resumed buying, propping up the index.

A market board in the Hana Bank dealing room in Jung-gu, Seoul displays market conditions on the 15th. The KOSPI opens at 6,145.75, up 178 points (2.98%) from the previous session; the KOSDAQ is at 1,138.42, up 16.54p (1.47%); and the won-dollar exchange rate starts trading at 1,473.5 won, down 7.70 won from the previous session./Courtesy of News1

As of 11:49 a.m., the KOSPI index is trading at 6,143.76, up 176.01 (2.95%) from the previous trading day. After opening near 6,141.6, up almost 3%, the index nearly broke above the 6,200 level but gave back part of its gains and is trading around 6,140.

Unlike early in the session, foreigners and institutions are net buying 494.5 billion won and 88.8 billion won, respectively. In the morning, foreigners and institutions were net sellers before turning net buyers intraday. Individuals turned to selling and are net selling 783.7 billion won.

Foreigners have been net buyers for two straight days. In particular, from the 7th to the 15th, they have kept buying except on the 13th over seven trading days.

By individual stocks, SK hynix jumped 6%, hitting an all-time high, while Samsung Electronics rose 3% and SK Square gained 5%. Samsung Electro-Mechanics also climbed 6% on news it will invest 1.8 trillion won in Vietnam to expand production capacity for high-value FC-BGA substrates.

At the same time, the KOSDAQ index is trading at 1,147.82, up 25.93 (2.31%) from the previous trading day. After opening at 1,140.62, the index is extending gains on institutional buying during the session.

Among individual stocks, Sam Chun Dang Pharm is up 9% on news it has begun procedures to acquire the transfer of S-PASS patent rights. Kolon TissueGene rose 8% and Alteogen 3%, with bio stocks broadly higher.

※ This article has been translated by AI. Share your feedback here.